Innovative strategies for targeting immune responses in aging lymph nodes

Nano Immune-Imaging Core

['FUNDING_P01'] · BRIGHAM AND WOMEN'S HOSPITAL · NIH-11083585

This study is exploring new ways to improve the health of aging lymph nodes to help prevent transplant rejection in heart transplant patients by delivering treatments directly where they're needed and watching how immune cells behave.

Quick facts

Phase['FUNDING_P01']
Study typeNih_funding
SexAll
SponsorBRIGHAM AND WOMEN'S HOSPITAL (nih funded)
Locations1 site (BOSTON, UNITED STATES)
Trial IDNIH-11083585 on ClinicalTrials.gov

What this research studies

This research focuses on developing advanced nanodelivery methods to modify the environment of aging lymph nodes, which are crucial for immune responses. By using targeted delivery of therapeutics, the project aims to inhibit the activation of harmful immune cells that can lead to transplant rejection. Additionally, it will utilize cutting-edge imaging techniques to track how immune cells interact within these lymph nodes. This approach could enhance the effectiveness of treatments for patients undergoing heart transplantation.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals undergoing heart transplantation, particularly those who are older and may have age-related immune challenges.

Not a fit: Patients who are not undergoing transplantation or those with conditions unrelated to immune response or aging may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved transplant outcomes and reduced rejection rates for heart transplant patients.

How similar studies have performed: Previous research in nanomedicine and immune modulation has shown promising results, indicating that this approach could be effective in enhancing transplant tolerance.

Where this research is happening

BOSTON, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.